Jump to content
RemedySpot.com

Course teaches drug industry to lie and cheat

Rate this topic


Guest guest

Recommended Posts

Course shows companies what NOT to put in writing (Reuters)

Posted on Thu Jan 8, 2009 1:05PM EST

NEW YORK (Reuters) - Want to avoid those embarrassing internal emails

containing concerns that an important product may be harmful, or

documents that could attract the attention of an ambitious prosecutor?

The Medical Technology Learning Institute and Compliance-Alliance is

offering: " Dangerous Documents: Avoiding Land Mines in Your FDA

Records and Emails " -- a course tailor-made for the drug industry and

medical device company executive anxious to cut down on pesky

multimillion-dollar legal settlements.

Dangerous Documents offers such helpful tips as: Instead of writing,

" We'll meet on Thursday to destroy the documents, " it's better to say,

" We'll meet on Thursday to implement our document retention policy. "

The course is the brain child of Compliance-Alliance founder

Singer, a former U.S. prosecutor who did litigation for the Food and

Drug Administration.

Singer is using her expertise to educate company officials on how to

write internal and external communications that do not contain

potential " landmines, " which she describes as anything that " if it's

uncovered, it explodes. "

" Documents are like diamonds, " she is fond of saying. " They are very

precious and they last forever. "

The Compliance-Alliance mission statement says the course will present

" the latest thinking on what it takes to achieve and maintain

compliance with FDA and CMS requirements. "

However, there appears to be more here than instruction on how to be

an upstanding corporate citizen and keep government agencies happy.

The course agenda reads more like a primer on how to avoid raising red

flags with the regulatory police or the suspicion of prosecutors and

product liability lawyers.

Some of the more eye catching topics listed in the program for the

$995 course include:

* Who can be held criminally liable under the Federal Food, Drug and

Cosmetic Act

* 18 words that will attract the attention of prosecutors or

plaintiffs' lawyers

* 8 common practices that are sure to get you in trouble

* The dangers in not monitoring employee emails

Singer insists this is not about how to bury negative data or avoid

getting caught for nefarious practices.

" I want to educate all employees on the ramifications of how

inappropriate statements can be used, " Singer said.

Indeed, in every personal injury trial in which Merck & Co defended

its handling of the withdrawn pain drug Vioxx, plaintiffs' lawyers

dredged up internal Merck memos that questioned company

interpretations of clinical safety data. Despite winning most of those

trials, Merck finally agreed to a $4.85 billion settlement.

" To survive in our litigious society, organizations need to have the

right communications culture. Everyone needs to understand what they

should, or should not, write in their emails, " Singer writes in a

pitch for the course.

Never use words like illegal or negligent when you can instead say,

" It could be argued that that doesn't comply with requirements " or

" perhaps we haven't been as careful as we should be, " Singer said.

She teaches that all written communication should be constructed with

the idea that it will be viewed by a third party who may try to use it

against the company.

Medtronic Inc, Allergan Inc, Sepracor Inc, Varian Medical Systems Inc

and Siemens AG, which last month agreed to pay $800 million to settle

a U.S. bribery probe, are among the health care companies with

employees who have taken the course.

" I'm a big proponent of the course, " said Morton, Medtronic's

director of regulatory affairs. " It's heightened the awareness of

everyone who participated. "

Among the pitfalls Singer discusses is what she calls the CYA (Cover

Your Ass) memo, in which an employee puts concerns in writing for the

files to show he or she raised the issue.

If the employee gets subpoenaed in a product liability case the CYA

memo will be used against the company, Singer says, " and it's not

going to protect you from the government. "

Another common misconception, Singer says, is the belief that putting

" confidential " or " internal use only " on a memo will keep it out of

the hands of investigators or government agencies.

" Writing 'confidential' doesn't mean anything. "

http://tech./news/nm/20090108/wr_nm/us_emails_3

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...